Mycophenolate REMS Program: CE Request for Grant Application

ACCME Newsletter (03/25/21) Vol. 12, No. 13

The U.S. Food and Drug Administration (FDA) has added accredited continuing education (CE) to the Mycophenolate Risk Evaluation and Mitigation Strategy (REMS) program. This is the second time the agency has included accredited CE a REMS. The objective is to uphold REMS-compliant, accredited CE for mycophenolate prescribers to enhance patient understanding of risks associated with the drug. The grant application process is open, with applications due by May 14.

Read More

Recent Stories
Improving Team Skills of Healthcare Practitioners

Impact of a Management Course for Pharmacists on Their Behaviors and the Health System's Capacity

Comparison of Four Methods of Paramedic Continuing Education in the Management of Pediatric Emergencies